GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
1 clinical trials · Sponsor
◉ Watch GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
| Record | Firm | Date |
|---|---|---|
| GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma (NCT05242146) | GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2022-05-24 |
Track GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.